141 related articles for article (PubMed ID: 38183507)
1. DNA methyltransferase 3a-induced hypermethylation of the fructose-1,6-bisphosphatase-2 promoter contributes to gastric carcinogenesis.
Huang Y; Lu H; Li H
Mol Biol Rep; 2024 Jan; 51(1):78. PubMed ID: 38183507
[TBL] [Abstract][Full Text] [Related]
2. Decreased fructose-1,6-bisphosphatase-2 expression promotes glycolysis and growth in gastric cancer cells.
Li H; Wang J; Xu H; Xing R; Pan Y; Li W; Cui J; Zhang H; Lu Y
Mol Cancer; 2013 Sep; 12(1):110. PubMed ID: 24063558
[TBL] [Abstract][Full Text] [Related]
3. Epigenetically deregulated miR-200c is involved in a negative feedback loop with DNMT3a in gastric cancer cells.
Li Y; Nie Y; Tu S; Wang H; Zhou Y; Du Y; Cao J; Ye M
Oncol Rep; 2016 Oct; 36(4):2108-16. PubMed ID: 27498672
[TBL] [Abstract][Full Text] [Related]
4. DNA methyltransferase 3A promotes cell proliferation by silencing CDK inhibitor p18INK4C in gastric carcinogenesis.
Cui H; Zhao C; Gong P; Wang L; Wu H; Zhang K; Zhou R; Wang L; Zhang T; Zhong S; Fan H
Sci Rep; 2015 Sep; 5():13781. PubMed ID: 26350239
[TBL] [Abstract][Full Text] [Related]
5. DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer.
Cui H; Hu Y; Guo D; Zhang A; Gu Y; Zhang S; Zhao C; Gong P; Shen X; Li Y; Wu H; Wang L; Zhao Z; Fan H
Oncogene; 2018 Aug; 37(32):4358-4371. PubMed ID: 29717263
[TBL] [Abstract][Full Text] [Related]
6. Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer.
Cui H; Wang L; Gong P; Zhao C; Zhang S; Zhang K; Zhou R; Zhao Z; Fan H
PLoS One; 2015; 10(4):e0123926. PubMed ID: 25874772
[TBL] [Abstract][Full Text] [Related]
7. Fructose-1,6-Bisphosphatase 2 Inhibits Oral Squamous Cell Carcinoma Tumorigenesis and Glucose Metabolism via Downregulation of c-Myc.
Wang L; Wang J; Shen Y; Zheng Z; Sun J
Oxid Med Cell Longev; 2022; 2022():6766787. PubMed ID: 35571245
[TBL] [Abstract][Full Text] [Related]
8. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer.
Liu X; Zhang J; Liu L; Jiang Y; Ji J; Yan R; Zhu Z; Yu Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2835-2844. PubMed ID: 29802960
[TBL] [Abstract][Full Text] [Related]
9. Promoter CpG island hypermethylation and down regulation of XRCC1 gene can augment in the gastric carcinogenesis events.
Nissar B; Kadla SA; Wani KA; Shah IA; Ganai BA
Mol Biol Rep; 2021 Jan; 48(1):405-412. PubMed ID: 33394233
[TBL] [Abstract][Full Text] [Related]
10. A functional polymorphism in the DNA methyltransferase-3A promoter modifies the susceptibility in gastric cancer but not in esophageal carcinoma.
Fan H; Liu D; Qiu X; Qiao F; Wu Q; Su X; Zhang F; Song Y; Zhao Z; Xie W
BMC Med; 2010 Feb; 8():12. PubMed ID: 20128888
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer.
Chen M; Zhang J; Li N; Qian Z; Zhu M; Li Q; Zheng J; Wang X; Shi G
PLoS One; 2011; 6(10):e25564. PubMed ID: 22039417
[TBL] [Abstract][Full Text] [Related]
12. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
13. Hsa_circ_0026344 suppresses gastric cancer progression via modulating the miR-1290/FBP2 axis.
Xiao G; Zhang T; Tan B; Hao H
Histol Histopathol; 2023 Sep; 38(9):1017-1028. PubMed ID: 36515277
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
15. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis.
Liu X; Wang X; Zhang J; Lam EK; Shin VY; Cheng AS; Yu J; Chan FK; Sung JJ; Jin HC
Oncogene; 2010 Jan; 29(3):442-50. PubMed ID: 19881551
[TBL] [Abstract][Full Text] [Related]
16. Transmembrane protein 106A is silenced by promoter region hypermethylation and suppresses gastric cancer growth by inducing apoptosis.
Xu D; Qu L; Hu J; Li G; Lv P; Ma D; Guo M; Chen Y
J Cell Mol Med; 2014 Aug; 18(8):1655-66. PubMed ID: 24975047
[TBL] [Abstract][Full Text] [Related]
17. MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area.
Yousuf A; Bhat MY; Pandith AA; Afroze D; Khan NP; Alam K; Shah P; Shah MA; Mudassar S
Cell Oncol (Dordr); 2014 Aug; 37(4):245-52. PubMed ID: 25008999
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.
Oue N; Kuraoka K; Kuniyasu H; Yokozaki H; Wakikawa A; Matsusaki K; Yasui W
Oncol Rep; 2001; 8(5):1085-9. PubMed ID: 11496321
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.
Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
